Please enable JavaScript to continue using this application.

Compare $IPSC vs $PALI | Chartloom

Compare

$IPSC vs $PALI

Century Therapeutics Inc · Palisade Bio Inc

IPSC

Century Therapeutics Inc

PALI

Palisade Bio Inc

Compare $IPSC vs $PALI

Comparing Century Therapeutics Inc and Palisade Bio Inc

IPSCCentury Therapeutics Inc

PALIPalisade Bio Inc

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

PALIPalisade Bio Inc

Market cap

$267M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-38.4%

52W performance

-23.0%

FCF yield

-6.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IPSC

PALI

Detailed metrics comparison

IPSC

Century Therapeutics Inc

PALI

Palisade Bio Inc

Market Cap

IPSC$265M

PALI$267M

Enterprise Value

IPSC$215M

PALI$142M

Price

IPSC$1.47

PALI$1.54

P/E Ratio

IPSCN/A

PALIN/A

P/S Ratio

IPSC2.41x

PALI534.63x

EV/Sales

IPSC1.98x

PALI284.28x

EV/EBITDA

IPSC0.00x

PALI0.00x

P/B Ratio

IPSC1.19x

PALI2.06x

P/FCF Ratio

IPSCN/A

PALIN/A

EV/FCF

IPSC-2.44x

PALI-7.81x

PEG Ratio

IPSCN/A

PALIN/A

Forward P/E (NTM)

IPSCN/A

PALIN/A

Forward P/S (NTM)

IPSCN/A

PALIN/A

Revenue (TTM)

IPSC$0

PALI$500K

Revenue Growth (YoY)

IPSC-100.0%

PALIN/A

Forward Rev Growth

IPSC385.7%

PALI42864.7%

Gross Margin (TTM)

IPSC0.0%

PALI0.0%

Operating Margin (TTM)

IPSC0.0%

PALI0.0%

EBITDA Margin (TTM)

IPSC0.0%

PALI-7069.6%

Net Margin (TTM)

IPSC0.0%

PALI-6388.2%

FCF Margin (TTM)

IPSCN/A

PALI-3638.0%

Net Income (TTM)

IPSC$-110M

PALI$-32M

FCF (TTM)

IPSC$-88M

PALI$-18M

EPS (TTM)

IPSC-$0.53

PALI-$0.15

ROE (TTM)

IPSC-5276.0%

PALI-3347.0%

ROA (TTM)

IPSC-4059.0%

PALI-3179.0%

ROIC (TTM)

IPSC-5276.0%

PALI-3345.0%

Cash

IPSC$50M

PALI$125M

Debt

IPSC$0

PALI$0

Net Cash/Debt

IPSC$50M

PALI$125M

Current Ratio (TTM)

IPSC8.28x

PALI24.26x

Quick Ratio (TTM)

IPSC7.94x

PALI23.97x

Debt/Equity (TTM)

IPSC0.00x

PALI0.00x

Debt/Assets (TTM)

IPSC0.0%

PALI0.0%

Interest Coverage (TTM)

IPSCN/A

PALIN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

PALI0.00x

Beta

IPSC1.74

PALI1.53

52W Performance

IPSC151.9%

PALI-23.0%

YTD Performance

IPSC47.8%

PALI-38.4%

% from 52W High

IPSC-51.6%

PALI-46.0%

% from 52W Low

IPSC237.9%

PALI16.7%

Asset Turnover (TTM)

IPSC0.31x

PALI0.00x

FCF Yield (TTM)

IPSC-33.3%

PALI-6.8%

Earnings Yield (TTM)

IPSC-41.4%

PALI-11.9%

Dividend Yield (TTM)

IPSCN/A

PALIN/A

Rule of 40

IPSC-100.0

PALI-3,638.0

EV/GP/RG

IPSCN/A

PALIN/A

Ticker research

View IPSC research View PALI research

Metric	IPSC Century Therapeutics Inc	PALI Palisade Bio Inc
Market & Valuation
Market Cap	$265M	$267M
Enterprise Value	$215M	$142M
Price	$1.47	$1.54
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	534.63x
EV/Sales	1.98x	284.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	2.06x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-7.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$500K
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	42864.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-7069.6%
Net Margin (TTM)	0.0%	-6388.2%
FCF Margin (TTM)	N/A	-3638.0%
Net Income (TTM)	$-110M	$-32M
FCF (TTM)	$-88M	$-18M
EPS (TTM)	-$0.53	-$0.15
ROE (TTM)	-5276.0%	-3347.0%
ROA (TTM)	-4059.0%	-3179.0%
ROIC (TTM)	-5276.0%	-3345.0%
Financial Health
Cash	$50M	$125M
Debt	$0	$0
Net Cash/Debt	$50M	$125M
Current Ratio (TTM)	8.28x	24.26x
Quick Ratio (TTM)	7.94x	23.97x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	1.53
52W Performance	151.9%	-23.0%
YTD Performance	47.8%	-38.4%
% from 52W High	-51.6%	-46.0%
% from 52W Low	237.9%	16.7%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.00x
FCF Yield (TTM)	-33.3%	-6.8%
Earnings Yield (TTM)	-41.4%	-11.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,638.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View PALI research

Valuation

P/S Ratio

IPSC

2.41x

PALI

534.63x

EV/FCF

PALI

-7.81x

IPSC

-2.44x

Growth & revenue

Revenue Growth TTM

IPSC

-100.0%

Forward Revenue Growth

PALI

42864.7%

IPSC

385.7%

Profitability & performance

Gross Margin

IPSC

0.0%

PALI

0.0%

ROE

PALI

-3347.0%

IPSC

-5276.0%

FCF Yield %

PALI

-6.8%

IPSC

-33.3%

52-Week Performance

IPSC

151.9%

PALI

-23.0%

Detailed metrics comparison

IPSC

Century Therapeutics Inc

PALI

Palisade Bio Inc

Market Cap

IPSC$265M

PALI$267M

Enterprise Value

IPSC$215M

PALI$142M

Price

IPSC$1.47

PALI$1.54

P/E Ratio

IPSCN/A

PALIN/A

P/S Ratio

IPSC2.41x

PALI534.63x

EV/Sales

IPSC1.98x

PALI284.28x

EV/EBITDA

IPSC0.00x

PALI0.00x

P/B Ratio

IPSC1.19x

PALI2.06x

P/FCF Ratio

IPSCN/A

PALIN/A

EV/FCF

IPSC-2.44x

PALI-7.81x

PEG Ratio

IPSCN/A

PALIN/A

Forward P/E (NTM)

IPSCN/A

PALIN/A

Forward P/S (NTM)

IPSCN/A

PALIN/A

Revenue (TTM)

IPSC$0

PALI$500K

Revenue Growth (YoY)

IPSC-100.0%

PALIN/A

Forward Rev Growth

IPSC385.7%

PALI42864.7%

Gross Margin (TTM)

IPSC0.0%

PALI0.0%

Operating Margin (TTM)

IPSC0.0%

PALI0.0%

EBITDA Margin (TTM)

IPSC0.0%

PALI-7069.6%

Net Margin (TTM)

IPSC0.0%

PALI-6388.2%

FCF Margin (TTM)

IPSCN/A

PALI-3638.0%

Net Income (TTM)

IPSC$-110M

PALI$-32M

FCF (TTM)

IPSC$-88M

PALI$-18M

EPS (TTM)

IPSC-$0.53

PALI-$0.15

ROE (TTM)

IPSC-5276.0%

PALI-3347.0%

ROA (TTM)

IPSC-4059.0%

PALI-3179.0%

ROIC (TTM)

IPSC-5276.0%

PALI-3345.0%

Cash

IPSC$50M

PALI$125M

Debt

IPSC$0

PALI$0

Net Cash/Debt

IPSC$50M

PALI$125M

Current Ratio (TTM)

IPSC8.28x

PALI24.26x

Quick Ratio (TTM)

IPSC7.94x

PALI23.97x

Debt/Equity (TTM)

IPSC0.00x

PALI0.00x

Debt/Assets (TTM)

IPSC0.0%

PALI0.0%

Interest Coverage (TTM)

IPSCN/A

PALIN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

PALI0.00x

Beta

IPSC1.74

PALI1.53

52W Performance

IPSC151.9%

PALI-23.0%

YTD Performance

IPSC47.8%

PALI-38.4%

% from 52W High

IPSC-51.6%

PALI-46.0%

% from 52W Low

IPSC237.9%

PALI16.7%

Asset Turnover (TTM)

IPSC0.31x

PALI0.00x

FCF Yield (TTM)

IPSC-33.3%

PALI-6.8%

Earnings Yield (TTM)

IPSC-41.4%

PALI-11.9%

Dividend Yield (TTM)

IPSCN/A

PALIN/A

Rule of 40

IPSC-100.0

PALI-3,638.0

EV/GP/RG

IPSCN/A

PALIN/A

Ticker research

View IPSC research View PALI research

Metric	IPSC Century Therapeutics Inc	PALI Palisade Bio Inc
Market & Valuation
Market Cap	$265M	$267M
Enterprise Value	$215M	$142M
Price	$1.47	$1.54
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	534.63x
EV/Sales	1.98x	284.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	2.06x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-7.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$500K
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	42864.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-7069.6%
Net Margin (TTM)	0.0%	-6388.2%
FCF Margin (TTM)	N/A	-3638.0%
Net Income (TTM)	$-110M	$-32M
FCF (TTM)	$-88M	$-18M
EPS (TTM)	-$0.53	-$0.15
ROE (TTM)	-5276.0%	-3347.0%
ROA (TTM)	-4059.0%	-3179.0%
ROIC (TTM)	-5276.0%	-3345.0%
Financial Health
Cash	$50M	$125M
Debt	$0	$0
Net Cash/Debt	$50M	$125M
Current Ratio (TTM)	8.28x	24.26x
Quick Ratio (TTM)	7.94x	23.97x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	1.53
52W Performance	151.9%	-23.0%
YTD Performance	47.8%	-38.4%
% from 52W High	-51.6%	-46.0%
% from 52W Low	237.9%	16.7%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.00x
FCF Yield (TTM)	-33.3%	-6.8%
Earnings Yield (TTM)	-41.4%	-11.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,638.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View PALI research